title: Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.
abstract: BACKGROUND
  Tissue factor (TF) is an initiator of coagulation. The serine protease factor Xa (FXa) is the convergence point of the extrinsic and intrinsic components of the coagulation cascade. In addition to its hemostatic function, FXa elicits inflammatory responses in endothelial cells that may be important in surgical procedures in which inflammation is triggered. This study tested the hypothesis that FXa can up-regulate TF on vascular endothelial cells by a mitogen-activated protein kinase (MAPK)- and NF-κB-dependent pathway.
  
  
  RESULTS
  Incubation of cultured human umbilical vein endothelial cells (HUVECs) with FXa increased TF protein expression and activity in a dose-dependent manner. Pre-incubation of HUVECs with the serine protease inhibitor antithrombin, which targets not only thrombin but also FXa and FIXa, inhibited FXa-induced TF expression, but the selective thrombin inhibitor hirudin did not inhibit FXa-induced TF expression, ruling out a thrombin-mediated pathway. After 10 min incubation with HUVECs, FXa rapidly induced P44/42 MAPK activation (immunoblotting of phosphorylated P44/42 MAPK) with a peak at 30 min. The MEK 1/2 inhibitor PD98059 partially reduced FXa-induced TF expression and activity (3.82 ± 0.11 vs 6.54 ± 0.08 fmol/min/cm(2), P < 0.05). NF-κB was activated by FXa, confirmed by cytoplasmic IkBα degradation and increased NF-κB P65 nuclear translocation. Interruption of the NF-κB pathway by the IkBα phosphorylation inhibitor Bay 11-7802 abrogated FXa-induced TF protein expression and activity (1.93 ± 0.02 versus 6.54 ± 0.08 fmol/min/cm(2), P < 0.05). However, inhibition of PI3 kinase by LY 294002 did not attenuate FXa-induced TF protein expression and activity.
  
  
  CONCLUSIONS
  (1) FXa up-regulates TF protein expression and activity in HUVECs, (2) FXa-induced up-regulation of TF is independent of the thrombin-PAR1 pathway, and (3) the MAPK and NF-κB pathways, but not PI3 kinase pathway, are involved in FXa-induced TF expression on human umbilical endothelial cells. FXa may be a feed-forward alternative mechanism of activating TF expression and activity, thereby increasing a procoagulant state or inflammation. This mechanism may be important in the pro-inflammatory state initiated by cardiac surgical procedures.
authors.affiliation: Cardiothoracic Research Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University Hospital Midtown, Atlanta, Georgia, USA.
authors.forename: Rong
authors.initials: R
authors.lastname: Jiang
authors.forename: Ning-Ping
authors.initials: NP
authors.lastname: Wang
authors.forename: Kenichi A
authors.initials: KA
authors.lastname: Tanaka
authors.forename: Jerrold H
authors.initials: JH
authors.lastname: Levy
authors.forename: Robert A
authors.initials: RA
authors.lastname: Guyton
authors.forename: Zhi-Qing
authors.initials: ZQ
authors.lastname: Zhao
authors.forename: Jakob
authors.initials: J
authors.lastname: Vinten-Johansen
mesh_terms: D000991:Antithrombins / Q000494:pharmacology; D002478:Cells, Cultured; D002867:Chromones / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015951:Factor Xa / Q000494:pharmacology*; D005419:Flavonoids / Q000494:pharmacology; D006629:Hirudins / Q000494:pharmacology; D006801:Humans; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D009025:Morpholines / Q000494:pharmacology; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000187:drug effects / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
chemical_list: D000991:Antithrombins; D002867:Chromones; D015951:Factor Xa; D005419:Flavonoids; D006629:Hirudins; D048369:MAP Kinase Kinase 1; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D009025:Morpholines; D016328:NF-kappa B; D009570:Nitriles; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D013450:Sulfones; D013917:Thrombin; D013925:Thromboplastin; C434003:3-(4-methylphenylsulfonyl)-2-propenenitrile; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
references.citation: Int J Cardiol. 2001 Apr;78(2):115-9
references.pmid: 11334654
references.citation: Shock. 2002 Feb;17(2):159-62
references.pmid: 11837793
references.citation: Blood. 2001 May 15;97(10):3109-16
references.pmid: 11342437
references.citation: J Thorac Cardiovasc Surg. 2002 Nov;124(5):942-9
references.pmid: 12407377
references.citation: Trends Cardiovasc Med. 2005 Feb;15(2):69-75
references.pmid: 15885573
references.citation: J Clin Invest. 1973 Nov;52(11):2745-56
references.pmid: 4355998
references.citation: Ann Thorac Surg. 2003 Jan;75(1):210-5; discussion 215-6
references.pmid: 12537218
references.citation: Cell. 2002 Apr;109 Suppl:S81-96
references.pmid: 11983155
references.citation: J Biol Chem. 2004 Apr 2;279(14):13729-37
references.pmid: 14736878
references.citation: Cardiovasc Res. 1996 Oct;32(4):733-42
references.pmid: 8915191
references.citation: Blood. 1998 Jun 1;91(11):4164-72
references.pmid: 9596663
references.citation: Biochem Pharmacol. 1999 Mar 15;57(6):603-10
references.pmid: 10037444
references.citation: Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1618-26
references.pmid: 15937101
references.citation: Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):461-6
references.pmid: 15550696
references.citation: J Immunol. 1998 Oct 15;161(8):4318-24
references.pmid: 9780208
references.citation: Biochim Biophys Acta. 2006 Aug;1763(8):860-9
references.pmid: 16765466
references.citation: J Biol Chem. 2004 Aug 20;279(34):36142-7
references.pmid: 15201277
references.citation: Arterioscler Thromb Vasc Biol. 1995 May;15(5):612-21
references.pmid: 7749875
references.citation: Circ Res. 2004 Aug 6;95(3):230-2
references.pmid: 15242972
references.citation: J Biol Chem. 2001 Sep 7;276(36):33428-34
references.pmid: 11445586
references.citation: J Thromb Haemost. 2003 Sep;1(9):1935-44
references.pmid: 12941034
references.citation: Blood. 2001 Feb 1;97(3):692-9
references.pmid: 11157486
references.citation: Cardiovasc Res. 2002 Feb 1;53(2):313-25
references.pmid: 11827681
references.citation: Circ Res. 1996 Aug;79(2):286-94
references.pmid: 8756006
references.citation: Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):281-9
references.pmid: 9974408
references.citation: J Biol Chem. 1996 Nov 8;271(45):28407-13
references.pmid: 8910465
references.citation: J Clin Invest. 1995 Jun;95(6):2510-9
references.pmid: 7539452
references.citation: FASEB J. 1995 Jul;9(10):883-9
references.pmid: 7615158
references.citation: Surgery. 2001 Nov;130(5):809-18
references.pmid: 11685190
references.citation: J Infect Dis. 2002 Nov 1;186(9):1270-6
references.pmid: 12402196
references.citation: Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):365-74
references.pmid: 9081693
references.citation: Ann Thorac Surg. 1996 Nov;62(5):1549-57
references.pmid: 8893613
references.citation: Thromb Res. 2001 Aug 15;103(4):281-97
references.pmid: 11562339
references.citation: Haematologica. 2002 Jul;87(7):740-5; discussion 745
references.pmid: 12091125
references.citation: J Biol Chem. 1994 Aug 19;269(33):20823-5
references.pmid: 8063696
references.citation: Circulation. 2002 Apr 16;105(15):1756-9
references.pmid: 11956113
references.citation: Biochemistry. 1997 Mar 18;36(11):3319-30
references.pmid: 9116010
references.citation: Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):E107-12
references.pmid: 11073863